Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05092854 · ClinicalTrials.gov registry record · NA
The Effect of AMP Human Sodium Bicarbonate Lotion on Dehydrated Heat Stress
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05092854: Completed NA study, sponsored by University of Connecticut.
NCT05092854 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05092854, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The primary purpose of the proposed study is to evaluate the effects of a topical sodium bicarbonate lotion (PR Lotion, AMP Human, Park City, UT) on measures of hydration status and fluid balance in humans when exposed to the heat while resting and during light/moderate aerobic exercise. A secondary purpose is to examine these same effects with two differing dosage patterns of the lotion. A tertiary purpose is to investigate the effect of an amino acid rehydration beverage in comparison to a placebo on measurements of hydration, subjective assessments of stress, and vestibular as well as musculoskeletal measures of fatigue for up to 24-hours after the completion of both passive and exertional heat stress within a dehydrated state.
Primary Outcome
Assessment of hydration status via collection of urine USG
Interventions
- OTHER Placebo Supplement
- OTHER PR Lotion - AMP Human Performance
- OTHER Placebo Lotion
- OTHER AminoVital - Rapid Recovery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-09-03 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
What the finished NCT05092854 record still lists
NCT05092854 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo Supplement is the first listed.
NCT05092854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05092854 about?
NCT05092854 is a clinical study titled "The Effect of AMP Human Sodium Bicarbonate Lotion on Dehydrated Heat Stress". The primary purpose of the proposed study is to evaluate the effects of a topical sodium bicarbonate lotion (PR Lotion, AMP Human, Park City, UT) on measures of hydration status and fluid balance in humans when exposed to the heat while resting and during light/moderate aerobic exercise. A secondary...
What is the current status of trial NCT05092854?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2021-09-03. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT05092854?
The interventions under investigation include: Placebo Supplement (OTHER), PR Lotion - AMP Human Performance (OTHER), Placebo Lotion (OTHER), AminoVital - Rapid Recovery (OTHER).
Who is sponsoring clinical trial NCT05092854?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05092854's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI